Home-based care model for patients with cirrhosis
The Hospital @ Home Model of Care: A Novel Healthcare Solution for the Management of Decompensated Cirrhosis
This study is testing a home care program for people with serious liver disease to see if it helps them feel better and be more satisfied with their care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Trial ID | NCT06396897 on ClinicalTrials.gov |
What this trial studies
This study explores the Hospital at Home (H@H) model for patients with decompensated cirrhosis, aiming to understand their perspectives on home-based care. The study is divided into three phases: the first phase occurs while participants are hospitalized, the second phase involves the implementation of the H@H program, and the third phase focuses on rehabilitation and self-management. The program allows patients to receive acute medical care and ancillary services in their homes, potentially improving their quality of care and satisfaction. The study seeks to assess the effectiveness and feasibility of this model in managing liver disease.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with chronic liver disease or cirrhosis who can live independently and have a caregiver present during the acute care phase.
Not a fit: Patients who are pregnant, incarcerated, or have severe comorbidities such as new hemodialysis or HIV with low CD4 counts may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance patient satisfaction and outcomes by providing effective care in the comfort of their homes.
How similar studies have performed: Previous studies have shown success with the Hospital at Home model in managing various conditions, indicating potential for effectiveness in this novel application for liver disease.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Enrolled into IUH's H@H program * At least 18 years of age * Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings * English speaking * Able to provide consent * Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge) * Able to perform activities of daily living independently * Lives within IU Health Home service area Exclusion Criteria: * Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss * Transplant of organ other than liver * Pregnant * Incarcerated * New hemodialysis * Blood pressure \< 90/60, Pulse \> 120, O2 \> 6L or \>2L above baseline * HIV+/CD4 count \< 200 * Receiving hospice services * Concurrent enrollment in a related research study
Where this trial is running
Indianapolis, Indiana
- IU School of Medicine — Indianapolis, Indiana, United States (Recruiting)
Study contacts
- Study coordinator: Regia Weber
- Email: reginaw@iu.edu
- Phone: 317-278-3584
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.